opt-6k_20220422.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2022

Commission File No. 001-39621

 

OPTHEA LIMITED

(Translation of registrant’s name into English)

 

Level 4

650 Chapel Street

South Yarra, Victoria, 3141

Australia

(Address of registrant’s principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F   Form 40-F  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

    Yes      No  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

    Yes      No  

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

    Yes      No  

 

 

 

 

 


 

 

EXHIBIT INDEX

 

Exhibit

 

Description

99.1

 

Initial Director’s Interest Notice – Susan Orr

 

1


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

OPTHEA LIMITED

 

(Registrant)

 

 

 

 

By:

/s/ Megan Baldwin

 

Name:

Megan Baldwin, Ph.D.

 

Title:

Chief Executive Officer and Managing Director

 

Date: 04/22/2022

2

opt-ex991_7.htm

Exhibit 99.1

 

Appendix 3X

Initial Director’s Interest Notice

 

 

Rule 3.19A.1

Appendix 3X

 

Initial Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/2001

 

Name of entity: Opthea Limited

ABN  32 006 340 567

 

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.  

 

Name of Director

Dr Susan C Orr

Date of appointment

21 April 2022

 

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

 

Number & class of securities

 

 

Nil

 

 

 


 

+ See chapter 19 for defined terms.

 

11/03/2002

Appendix 3X  Page 1

 


Appendix 3X

Initial Director’s Interest Notice

 

 

 

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

 

Name of holder & nature of interest

Note: Provide details of the circumstances giving rise to the relevant interest

 

Not applicable

 

Number & class of Securities

 

 

 

Not Applicable

 

Part 3 – Director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract

Nil

Nature of interest

 

 

 

Name of registered holder

(if issued securities)

 

 

No. and class of securities to which interest relates

 

 

 

 

+ See chapter 19 for defined terms.

 

Appendix 3X  Page 2

11/3/2002